Click Diagnostics
Menlo Park, US · Founded 2012 · Delaware corporation · 1 known investors
Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis. It connects users with licensed providers who can prescribe treatment upon a positive result, aimed at consumers managing their sexual health without visiting a clinic.
Founders & leadership
AD
ADAM DE LA ZERDANamed on SEC filing
Board
AS
AJIT SINGHBoard director
JB
JEROME BEHARBoard director
SR
STEVEN ROSSTONBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$235M disclosed across 4 rounds · 2015–2022
▶$108.6MraisedMar 2022 · 45 investors · Other Health CareRule 506(b)
▶$108.6MraisedMar 2022 · 45 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott E. MendelDirector
- Mark IbisonExecutive Officer
- Jerome BeharDirector
- Thomas M. PrescottDirector
- Adam de la ZerdaExecutive Officer, Director
- Terri BresenhamDirector
- Eric MoessingerDirector
- John KuoExecutive Officer
- Amit ShahDirector
- Shlomo MelmedDirector
- Offering amount
- $156.4M
- Amount sold
- $108.6M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100.8MraisedMay 2019 · 101 investors · Other TechnologyRule 506(b)
▶$100.8MraisedMay 2019 · 101 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory LoneyExecutive Officer
- JEROME BEHARDirector
- AJIT SINGHExecutive Officer, Director
- ADAM DE LA ZERDAExecutive Officer, Director
- David EngmanDirector
- Offering amount
- $133.6M
- Amount sold
- $100.8M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.5MraisedJan 2018 · 21 investors · Other TechnologyRule 506(b)
▶$9.5MraisedJan 2018 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- ADAM DE LA ZERDAExecutive Officer, Director
- AJIT SINGHExecutive Officer, Director
- JEROME BEHARDirector
- STEVEN ROSSTONDirector
- Offering amount
- $15M
- Amount sold
- $9.5M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedNov 2015 · 30 investors · BiotechnologyRule 506(b)
▶$16MraisedNov 2015 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- AJIT SINGHExecutive Officer, Director
- JEROME BEHARDirector
- ADAM DE LA ZERDADirector, Promoter
- STEVEN ROSSTONDirector
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.4M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Click Diagnostics do?
- Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis. It connects users with licensed providers who can prescribe treatment upon a positive result, aimed at consumers managing their sexual health without visiting a clinic.
- Who are Click Diagnostics's investors?
- Click Diagnostics's investors include Jam Fund.
- How much funding has Click Diagnostics raised?
- Click Diagnostics has disclosed $235M raised across 4 rounds.
- Where is Click Diagnostics headquartered?
- Click Diagnostics is headquartered in Menlo Park, US.